Familial hypercholesterolaemia trials in Vietnam

1 trial · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 3Not yet taking people in Vietnam
  A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin, and Placebo on LDL-C in LLT-naïve Patients

  Where

  Haiphong, Hà Nội, Hochiminh, Hochiminh City, Ho Chi Minh City

  Age

  18 years and over

  People

  204 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07930507